We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$819M
AUM Growth
+$48.9M
Cap. Flow
+$21.4M
Cap. Flow %
2.61%
Top 10 Hldgs %
16.19%
Holding
936
New
99
Increased
366
Reduced
325
Closed
78

Top Buys

Rank Stock Value
1
FTCS icon
First Trust Capital Strength ETF
FTCS
+$2.07M
2
FTC icon
First Trust Large Cap Growth AlphaDEX Fund
FTC
+$1.86M
3
FVD icon
First Trust Value Line Dividend Fund
FVD
+$1.73M
4
FV icon
First Trust Dorsey Wright Focus 5 ETF
FV
+$1.68M
5
CELG
Celgene Corp
CELG
+$1.58M

Top Sells

Rank Stock Value
1
GGP
GGP Inc.
GGP
+$1.17M
2
AGN.PRA
Allergan plc
AGN.PRA
+$1.14M
3
GM icon
General Motors
GM
+$1.13M
4
MDC
M.D.C. Holdings, Inc.
MDC
+$944K
5
UFI icon
UNIFI
UFI
+$931K

Sector Composition

Rank Sector Weight
1 Financials 10.7%
2 Healthcare 10.13%
3 Technology 10.1%
4 Consumer Discretionary 8.78%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVAX icon
801
Novavax
NVAX
$1.23B
$39K ﹤0.01%
1,582
– –
TOVX icon
802
Theriva Biologics
TOVX
$10.2M
$39K ﹤0.01%
9
+3
+50% +$18.7K
YOGA
803
DELISTED
YogaWorks, Inc. Common Stock
YOGA
$39K ﹤0.01%
+13,779
New +$36.4K
GNW icon
804
Genworth Financial
GNW
$3.8B
$36K ﹤0.01%
11,520
-3,000
-21% -$10.4K
JRJC
805
DELISTED
China Finance Online Co., Ltd.
JRJC
$36K ﹤0.01%
1,350
– –
PRQR icon
806
ProQR Therapeutics
PRQR
$243M
$35K ﹤0.01%
+10,720
New +$38.5K
ACHN
807
DELISTED
Achillion Pharmaceuticals
ACHN
$35K ﹤0.01%
+12,000
New +$43.6K
SSI
808
DELISTED
Stage Stores Inc
SSI
$34K ﹤0.01%
20,000
– –
ERN
809
DELISTED
Erin Energy Corp
ERN
$28K ﹤0.01%
10,000
– –
APPS icon
810
Digital Turbine
APPS
$1.02B
$27K ﹤0.01%
15,000
+5,000
+50% +$8.22K
RAD
811
DELISTED
Rite Aid Corporation
RAD
$27K ﹤0.01%
+675
New +$24.1K
IMUC
812
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$27K ﹤0.01%
86,530
+25,000
+41% +$8.51K
CYTO
813
DELISTED
Altamira Therapeutics Ltd
CYTO
$26K ﹤0.01%
1
– –
AXAS
814
DELISTED
Abraxas Petroleum Corp
AXAS
$25K ﹤0.01%
+500
New +$20.8K
AST
815
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$25K ﹤0.01%
+11,000
New +$27.8K
ARGS
816
DELISTED
Argos Therapeutics, Inc.
ARGS
$23K ﹤0.01%
7,600
+2,000
+36% +$6.71K
KPRX icon
817
Kiora Pharmaceuticals
KPRX
$11.3M
$21K ﹤0.01%
+4
New +$24.7K
CXRX
818
DELISTED
Concordia International Corp. Common Stock
CXRX
$20K ﹤0.01%
+30,000
New +$20.6K
TTNP
819
DELISTED
Titan Pharmaceuticals
TTNP
$18K ﹤0.01%
+4
New +$24.9K
AFMD
820
DELISTED
Affimed
AFMD
$16K ﹤0.01%
+1,200
New +$22.8K
PSV
821
DELISTED
Hermitage Offshore Services Ltd.
PSV
$15K ﹤0.01%
1,223
+20
+2% +$259
VXRT
822
DELISTED
Vaxart
VXRT
$14K ﹤0.01%
2,249
+964
+75% +$6.74K
CARM
823
DELISTED
Carisma Therapeutics
CARM
$13K ﹤0.01%
+811
New +$15.1K
MBOT icon
824
Microbot Medical
MBOT
$115M
$10K ﹤0.01%
+667
New +$11.3K
PLX icon
825
Protalix BioTherapeutics
PLX
$191M
$10K ﹤0.01%
1,500
-800
-35% -$5.4K
31 32
33
34 35

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q4 2017 Portfolio in Review

As of Q4 2017, Wedbush Securities held 936 positions worth $819M, up 6.3% from $770M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Wedbush Securities's Q4 2017 filing shows 99 new, 366 increased, 325 reduced and 78 closed positions. Its largest new stake was First Trust Capital Strength ETF: 41,703 shares worth $2.13M. The largest sale was GGP Inc., an estimated $1.17M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Technology.

  • Wedbush Securities's largest Q4 2017 buy was First Trust Capital Strength ETF: 41,703 shares worth $2.13M.
  • Wedbush Securities added most to First Trust Value Line Dividend Fund in Q4 2017, an estimated $1.73M increase.
  • Wedbush Securities's biggest Q4 2017 reduction was GGP Inc., cutting an estimated $1.17M.
  • Wedbush Securities fully exited iShares 10+ Year Investment Grade Corporate Bond ETF in Q4 2017, selling an estimated $897K.
  • Wedbush Securities's ten largest holdings make up 16% of its $819M portfolio in Q4 2017.
  • Wedbush Securities opened 99 new positions and closed 78 in Q4 2017.
  • Wedbush Securities's portfolio value rose 6.3% quarter-over-quarter to $819M.

Based on Wedbush Securities's 13F filing for Q4 2017, filed 9 Feb 2018.